DoP junks Skymap Pharma review plea against NPPA
New Delhi: In a major setback to Skymap Pharmaceuticals Limited, the Department of Pharmaceuticals (DoP) has rejected the review application filed by the drugmaker against a notification issued by the National Pharmaceutical Pricing Authority (NPPA) for fixing the retail price of Fluconazole Tablets 300mg.
DoP upholds NPPA’s method of retail price fixation of drugs
The Department, in different speaking orders on each review petition, upheld the NPPA’s decision and rejected the review application. DoP noted that NPPA acted largely in line with the basic premise of the Pricing Policy, 2012, of ensuring affordable and reasonably priced medicines to the consumers while enabling the industry to grow, which
DoP asks NPPA to review, verify Bharat Serum and Vaccine's
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the National Pharmaceutical Pricing Authority (NPPA) instructing to verify the applicability of GST factor by cross-checking the documents submitted by BSVL pertaining to the formulation Human Normal Immunoglobulin.
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the Na Products Suppliers
Itch Guard price ceiling: Government asks NPPA to consider
The central government has asked the National Pharmaceutical Pricing Authority (NPPA) to consider the price data of popular anti-fungal skin cream Itch Guard and then re-fix the ceiling price...
